Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SATISFACTION bowel preparation study
2019-002856-18Phase 2Completed
- Sponsor
- NTC Pharma
- Start
- Mar 2020
- Modality
- Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial comparing Pearlitol PF arm with Moviprep arm (2 arms). Primary endpoints: Phase II dose-finding primary endpoint and Bowel cleansing adequacy. Started Mar 2020; status: completed.
02
Drugs
mannitolmacrogol
Beyond the preview
Go deeper on 2019-002856-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-002856-18.